| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10165092 | JACC: Heart Failure | 2014 | 7 Pages |
Abstract
The GNB3 TT genotype was associated with greater therapeutic effect of FDC I/H in A-HeFT. The role of the GNB3 genotype for targeting therapy with FDC I/H deserves further study.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Dennis M. MD, MS, Anne L. MD, S. William PhD, Manuel MD, Clyde W. MD, MSc, Karen BS, Jay N. MD, Arthur M. MD, PhD,